Neurobiology of Anxiety Disorders in the Digital Era: From Stress Pathways to Precision Psychiatry
Abstract
Introduction: The digital era has transformed daily life, yet its impact on the neurobiology of anxiety disorders remains incompletely understood. Epidemiological data show a 25% global increase in anxiety prevalence since 2020, with young adults and Southeast Asian populations disproportionately affected. Methods: A systematic search of PubMed, Scopus, and Google Scholar (January 2020–March 2026) was conducted using terms combining anxiety disorders, neurobiology, and digital technology. Included articles were peer-reviewed human studies (meta-analyses, systematic reviews, RCTs, multicenter fMRI studies). Each reference was manually cross-checked for verifiability. Results: Chronic digital stressors activate HPA axis hyperreactivity and impair prefrontal inhibition of the amygdala, leading to maladaptive neuroplasticity. Digital phenotyping using smartphone sensors achieves 78–82% accuracy for anxiety detection. fMRI studies have identified six distinct neurobiological biotypes of anxiety that predict differential treatment response. VRET, neurofeedback, and rTMS show efficacy comparable to standard therapies. In Southeast Asia, anxiety prevalence varies widely (1.5–88.1%) with major barriers including limited neuroimaging access and algorithmic cultural bias. Conclusion: The digital environment reshapes anxiety neurobiology but also enables precision diagnostics and therapeutics. Context-sensitive, culturally adapted implementation is urgently needed, particularly in Southeast Asia.

